163 related articles for article (PubMed ID: 37829123)
1. A novel GPI-anchored dominant-negative TGF-β receptor II renders T cells unresponsive to TGF-β signaling.
Petersen SH; Al Badawy K; Hopkins R; Vu DL; Rahmani M; Maia SMP; Connolly JE
Mol Ther Oncolytics; 2023 Dec; 31():100730. PubMed ID: 37829123
[TBL] [Abstract][Full Text] [Related]
2. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II.
Guerrero-Esteo M; Sanchez-Elsner T; Letamendia A; Bernabeu C
J Biol Chem; 2002 Aug; 277(32):29197-209. PubMed ID: 12015308
[TBL] [Abstract][Full Text] [Related]
3. A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation.
Zhu HJ; Sizeland AM
J Biol Chem; 1999 Apr; 274(17):11773-81. PubMed ID: 10206994
[TBL] [Abstract][Full Text] [Related]
4. Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.
Luo K; Lodish HF
EMBO J; 1996 Sep; 15(17):4485-96. PubMed ID: 8887540
[TBL] [Abstract][Full Text] [Related]
5. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma.
Knaus PI; Lindemann D; DeCoteau JF; Perlman R; Yankelev H; Hille M; Kadin ME; Lodish HF
Mol Cell Biol; 1996 Jul; 16(7):3480-9. PubMed ID: 8668164
[TBL] [Abstract][Full Text] [Related]
6. Targeting all transforming growth factor-β isoforms with an Fc chimeric receptor impairs tumor growth and angiogenesis of oral squamous cell cancer.
Takahashi K; Akatsu Y; Podyma-Inoue KA; Matsumoto T; Takahashi H; Yoshimatsu Y; Koinuma D; Shirouzu M; Miyazono K; Watabe T
J Biol Chem; 2020 Sep; 295(36):12559-12572. PubMed ID: 32631954
[TBL] [Abstract][Full Text] [Related]
7. Glycosylphosphatidylinositol-anchored proteins regulate transforming growth factor-beta signaling in human keratinocytes.
Tam BY; Finnson KW; Philip A
J Biol Chem; 2003 Dec; 278(49):49610-7. PubMed ID: 14504277
[TBL] [Abstract][Full Text] [Related]
8. USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII.
Xie F; Zhou X; Li H; Su P; Liu S; Li R; Zou J; Wei X; Pan C; Zhang Z; Zheng M; Liu Z; Meng X; Ovaa H; Ten Dijke P; Zhou F; Zhang L
EMBO J; 2022 Aug; 41(16):e108791. PubMed ID: 35811497
[TBL] [Abstract][Full Text] [Related]
9. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
[TBL] [Abstract][Full Text] [Related]
10. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II.
Song K; Krebs TL; Danielpour D
J Biol Chem; 2006 Mar; 281(12):7765-74. PubMed ID: 16428382
[TBL] [Abstract][Full Text] [Related]
11. Ovarian transforming growth factor-beta (TGF-beta) receptors: in-vitro effects of follicle stimulating hormone, epidermal growth factor and TGF-beta on receptor expression in human preantral follicles.
Roy SK; Kole AR
Mol Hum Reprod; 1998 Mar; 4(3):207-14. PubMed ID: 9570266
[TBL] [Abstract][Full Text] [Related]
12. A novel TGF-β receptor II mutation (I227T/N236D) promotes aggressive phenotype of oral squamous cell carcinoma via enhanced EGFR signaling.
Son HK; Kim D; Lim Y; Kim J; Park I
BMC Cancer; 2020 Nov; 20(1):1163. PubMed ID: 33246423
[TBL] [Abstract][Full Text] [Related]
13. Albumin endocytosis in endothelial cells induces TGF-beta receptor II signaling.
Siddiqui SS; Siddiqui ZK; Malik AB
Am J Physiol Lung Cell Mol Physiol; 2004 May; 286(5):L1016-26. PubMed ID: 14729511
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta (TGF-beta) type I and type II receptors are both required for TGF-beta-mediated extracellular matrix production in lung fibroblasts.
Zhao Y
Mol Cell Endocrinol; 1999 Apr; 150(1-2):91-7. PubMed ID: 10411303
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of TbetaRII-B, a variant of the type II TGF-beta receptor, in human chondrocytes.
Parker WL; Finnson KW; Soe-Lin H; Knaus P; Philip A
Osteoarthritis Cartilage; 2007 Apr; 15(4):442-53. PubMed ID: 17175180
[TBL] [Abstract][Full Text] [Related]
16. TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor.
Kim YW; Park J; Lee HJ; Lee SY; Kim SJ
Biochem J; 2012 Aug; 445(3):403-11. PubMed ID: 22571197
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta1 receptor II is downregulated by E1A in adenovirus-infected cells.
Tarakanova VL; Wold WS
J Virol; 2003 Sep; 77(17):9324-36. PubMed ID: 12915548
[TBL] [Abstract][Full Text] [Related]
18. Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy.
Won J; Kim H; Park EJ; Hong Y; Kim SJ; Yun Y
Cancer Res; 1999 Mar; 59(6):1273-7. PubMed ID: 10096559
[TBL] [Abstract][Full Text] [Related]
19. Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells.
Anumanthan G; Halder SK; Osada H; Takahashi T; Massion PP; Carbone DP; Datta PK
Br J Cancer; 2005 Nov; 93(10):1157-67. PubMed ID: 16251876
[TBL] [Abstract][Full Text] [Related]
20. PDGF receptor-α promotes TGF-β signaling in hepatic stellate cells via transcriptional and posttranscriptional regulation of TGF-β receptors.
Liu C; Li J; Xiang X; Guo L; Tu K; Liu Q; Shah VH; Kang N
Am J Physiol Gastrointest Liver Physiol; 2014 Oct; 307(7):G749-59. PubMed ID: 25169976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
